Toward the end of trading Wednesday, the Dow traded up 0.31% to 26923.91 while the NASDAQ fell 0.09% to 10670.29. The S&P also rose, gaining 0.26% to 3,265.71.
Benzinga · 07/22 18:48
Oragenics rallies on encouraging data supporting potential COVID-19 vaccine
Nano cap Oragenics (NYSEMKT:OGEN) jumps 36% premarket on robust volume in reaction to its announcement that its in-licensed SARS-CoV-2 spike protein genera
seekingalpha · 07/22 18:19
Oragenics rallies on encouraging data supporting potential COVID-19 vaccine
Seeking Alpha - Article · 07/22 13:19
Organics shares are trading higher after the company said its preclinical study showed that the SARS-CoV-2 spike protein licensed by the company from NIH produces neutralizing antibodies.
Benzinga · 07/22 12:54
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies
Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as an antibiotic, as well as other homolog antibiotic product candidates and AG013 for the treatment of oral mucositis in patients undergoing treatment for cancer. The Company have developed other product such as weight loss candidate, LPT3-04 and SMaRT Replacement Therapy.